Transactions & Cas
Schellenberg Wittmer advises AOP Orphan Pharmaceuticals on its license agreement with Eagle Pharmaceuticals
09.08.2021
Schellenberg Wittmer assisted AOP Orphan Pharmaceuticals on its recent license agreement with Eagle Pharmaceuticals regarding U.S. rights for Landiolol, a beta blocker.
The team of Schellenberg Wittmer consisted of Philipp Groz and Prof. Dr. Peter Georg Picht (both Intellectual Property and Life Sciences) as well as Roland Mathys and Amalie Wijesundera (both Data Protection).
Partager
Plus d'informations
View Press ReleaseContact
Schellenberg Wittmer conseille Procimmo SA dans l'obtention de l'autorisation en tant que Direction de fonds
17.12.2024
Schellenberg Wittmer conseille dans le cadre de la transformation des fonds immobiliers de Procimmo
10.12.2024
Schellenberg Wittmer a conseillé le financement de l'acquisition de Neschen Coating par ATP
08.10.2024